Total Funding
57
64
Total FundingSeries A raised
Growth Score 57 in past quarter
-7 pts
Heat Score 64 in past quarter
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
123268
Hallura is a biotechnology company develops Hyaluronic Acid Dermal Fillers for natural and soft aesthetic treatments.
- Stephane Meunier: CEO and Co-Founder
- Alona Gellerman: Co-Founder
About the Company
Hallura is a biotechnology company for natural and soft aesthetic treatments. The company developing a new generation of Hyaluronic Acid (HA) Dermal Fillers and intends to use the funds to complete its clinical trials and register its proprietary Hyaluronic Acid Dermal Fillers in Europe.
Hallura aims to build a new technology platform in order to
create the next generation of dermal fillers for aesthetic medicine and overcome the limitations of current products. The company was founded in November 2017 and is based in Yoqneam, Israel.